Albert Cha, Director at KalVista Pharmaceuticals, holds 1.14M shares in KalVista Pharmaceuticals (Ticker: KALV), holds ― shares in Aclaris Therapeutics (Ticker: ACRS), holds 2.05M shares in Biohaven Pharmaceutical Holding Co (Ticker: BHVN). Most recently, Albert Cha Bought ― shares of KalVista Pharmaceuticals on Nov 03, 2020 for an estimated value of 1.99M.